Pitt's School of Medicine earned research funding from the Jewish Healthcare Foundation

The Jewish Healthcare Foundation will fund a study from Pitt’s School of Medicine that aims to reduce preventable adverse drug events among patients who transition between the hospital and skilled nursing facilities.

Through the Medication Error Avoidance at Region Scale (MEARS) study, a team in Pitt’s Department of Biomedical Informatics will develop a clinical decision support intervention that will help pharmacists assess risks for individual patients and monitor safety at a population level.

The Pitt MEARS study team will also collaborate with the Carnegie Mellon University Initiative for Patient Safety Research to develop and test predictive and analytic models focused on patient safety and medication error avoidance. The study will help clarify the most important data elements for accurately determining risk for patients as they transition between care settings.